111 related articles for article (PubMed ID: 20665677)
21. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid.
Takarada T; Hinoi E; Kambe Y; Sahara K; Kurokawa S; Takahata Y; Yoneda Y
Eur J Pharmacol; 2007 Dec; 575(1-3):1-11. PubMed ID: 17698058
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous delivery of BMP-2 factor and anti-osteoporotic drugs using hyaluronan-assembled nanocomposite for synergistic regulation on the behaviors of osteoblasts and osteoclasts in vitro.
Zhang Y; Hu Y; Luo Z; Shen X; Mu C; Cai K
J Biomater Sci Polym Ed; 2015; 26(5):290-310. PubMed ID: 25585099
[TBL] [Abstract][Full Text] [Related]
23. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
Schindeler A; Little DG
Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296
[TBL] [Abstract][Full Text] [Related]
24. Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells.
Trojani C; Boukhechba F; Scimeca JC; Vandenbos F; Michiels JF; Daculsi G; Boileau P; Weiss P; Carle GF; Rochet N
Biomaterials; 2006 Jun; 27(17):3256-64. PubMed ID: 16510180
[TBL] [Abstract][Full Text] [Related]
25. Regulation of osteoblast and osteoclast functions by FGF-6.
Bosetti M; Leigheb M; Brooks RA; Boccafoschi F; Cannas MF
J Cell Physiol; 2010 Nov; 225(2):466-71. PubMed ID: 20458746
[TBL] [Abstract][Full Text] [Related]
26. Modulation of human osteoclastogenesis and osteoblastogenesis by lycopene.
Costa-Rodrigues J; Fernandes MH; Pinho O; Monteiro PRR
J Nutr Biochem; 2018 Jul; 57():26-34. PubMed ID: 29655028
[TBL] [Abstract][Full Text] [Related]
27. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
28. Effect of estrogen on the activity and growth of human osteoclasts in vitro.
Chen FP; Wang KC; Huang JD
Taiwan J Obstet Gynecol; 2009 Dec; 48(4):350-5. PubMed ID: 20045755
[TBL] [Abstract][Full Text] [Related]
29. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
30. Estrogen blocks parathyroid hormone-stimulated osteoclast-like cell formation in modulating differentiation of mouse marrow stromal cells in vitro.
Liu BY; Wu PW; Hsu YT; Leu JS; Wang JT
J Formos Med Assoc; 2002 Jan; 101(1):24-33. PubMed ID: 11911034
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of carboxymethylcellulose, hydroxypropylmethylcellulose, and aluminum hydroxide as potential carriers for rhBMP-2.
Santa-Comba A; Pereira A; Lemos R; Santos D; Amarante J; Pinto M; Tavares P; Bahia F
J Biomed Mater Res; 2001 Jun; 55(3):396-400. PubMed ID: 11255193
[TBL] [Abstract][Full Text] [Related]
32. Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts.
Nakamura YS; Hakeda Y; Takakura N; Kameda T; Hamaguchi I; Miyamoto T; Kakudo S; Nakano T; Kumegawa M; Suda T
Stem Cells; 1998; 16(3):229-38. PubMed ID: 9617898
[TBL] [Abstract][Full Text] [Related]
33. Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts.
Hu YS; Zhou H; Myers D; Quinn JM; Atkins GJ; Ly C; Gange C; Kartsogiannis V; Elliott J; Kostakis P; Zannettino AC; Cromer B; McKinstry WJ; Findlay DM; Gillespie MT; Ng KW
J Bone Miner Res; 2004 Jan; 19(1):89-99. PubMed ID: 14753741
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of osteoclast differentiation by daidzein via caspase 3.
Rassi CM; Lieberherr M; Chaumaz G; Pointillart A; Cournot G
J Bone Miner Res; 2002 Apr; 17(4):630-8. PubMed ID: 11918220
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
[TBL] [Abstract][Full Text] [Related]
36. Osteoclastogenesis is negatively regulated by D-serine produced by osteoblasts.
Takarada T; Takarada-Iemata M; Takahata Y; Yamada D; Yamamoto T; Nakamura Y; Hinoi E; Yoneda Y
J Cell Physiol; 2012 Oct; 227(10):3477-87. PubMed ID: 22252936
[TBL] [Abstract][Full Text] [Related]
37. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone.
Hie M; Tsukamoto I
Eur J Pharmacol; 2011 Oct; 668(1-2):140-6. PubMed ID: 21806983
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
[TBL] [Abstract][Full Text] [Related]
39. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY
Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364
[TBL] [Abstract][Full Text] [Related]
40. Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors.
Mbalaviele G; Jaiswal N; Meng A; Cheng L; Van Den Bos C; Thiede M
Endocrinology; 1999 Aug; 140(8):3736-43. PubMed ID: 10433234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
